Dr. Natàlia Carreras leads the Bioinformatics Department at TruDiagnostic, where her team processes DNA methylation data, ensures data quality, and develops new epigenetic biomarkers of aging. Their work focuses on delivering accurate, scalable, and reliable biological age estimates and other methylation-based health insights from DNA methylation data. She graduated in Genetics and earned an MSc in Bioinformatics from the Autonomous University of Barcelona, followed by a PhD in Biomedicine from Pompeu Fabra University. Based in Europe, Natàlia is the author of numerous peer-reviewed publications on DNA methylation and biomarkers of aging.

Nathaniel serves as Vice President of Accounting and Finance at TruDiagnostic, where he leads the company's financial operations, reporting, and accounting functions. He brings roughly fifteen years of experience spanning public accounting, private-equity-backed businesses, startups, and publicly traded companies, having previously managed finance and accounting at Wild Health.

Brenda serves as Vice President of Commercial Development and Strategic Growth at TruDiagnostic, where she leads strategic partnerships, industry collaborations, and research-driven growth initiatives. With a strong background in genomics and diagnostics commercialization, she helps connect TruDiagnostic's epigenetic platform with healthcare, life sciences, and research partners advancing data-driven approaches to prevention, precision health, and clinical discovery.

Dr. Loren Clarke serves as Vice President of Medical Affairs at TruDiagnostic, where he helps translate the company's epigenetic science into clinical practice and supports its medical and provider engagement strategy. A physician based in Park City, Utah, he brings deep experience in diagnostics and medical affairs, including prior leadership as Chief Medical Officer at DermTech.

Melanie is the CEO of Tally Health, a consumer biotech company advancing the science of longevity through proprietary epigenetic testing and aging supplements. An experienced CEO, board director, and investor with deep expertise at the intersection of consumer, healthcare, and technology, Melanie brings more than 20 years of leadership experience scaling mission-driven businesses, guiding companies through complex capital events, and building data-driven organizations that deliver long-term value to shareholders and stakeholders alike. Prior to Tally, Melanie held pivotal leadership roles including COO & CFO at TMRW Life Sciences, CFO at Refinery29, and SVP at Everyday Health, where she led multiple M&A integrations, IPO readiness, and large-scale organizational transformation. Melanie also sits on the Board of Sollis Health.

Jon serves as Executive Vice President of Payor Services at TruDiagnostic, where he leads efforts to expand access to epigenetic and longevity diagnostics through health plans and payor partnerships. A healthcare innovation executive based in New York, he focuses on building the commercial and reimbursement pathways that bring advanced preventive testing into mainstream healthcare.

Anastasia Medytska has spent her career scaling health companies from early stage to real impact — building the brands, products, tools and teams that turn promising ideas into businesses people actually use. As President, she oversees the end-to-end operations of the company, including product, technology and growth. Before TruDiagnostic, she was CMO at Wild Health, where she scaled a single clinic into a nationwide precision health platform and led the company through an acquisition. Earlier roles at SimpleHealth and Ever/Body gave her a foundation in growth, brand, and retention across some of the most competitive corners of consumer health. Prior to health, she spent time at Uber, where she built the company's first rewards program and scaled ridesharing locally and globally. She has also served as an advisor to Extension Health and several other longevity-focused companies. Originally from Ukraine, a lifelong New Yorker, and a Vanderbilt graduate, Anastasia's work is a direct extension of a lifelong obsession with health and longevity — she considers herself lucky that she gets to make it her job!

Jessica brings over a decade of expertise in epidemiology, environmental health, and data-driven insights to her role as Medical Science Liaison at TruDiagnostic. She earned her Master of Public Health in Environmental Health and Epidemiology from Yale University and a Bachelor of Science in Environmental Toxicology from the University of California, Davis. Prior to joining TruDiagnostic, Jessica served as Epidemiologist and Program Manager at the Maine Center for Disease Control and Prevention, where she led statewide environmental public health tracking initiatives, developed novel surveillance systems, and partnered with stakeholders to translate complex health data into action. At TruDiagnostic, Jessica leverages her background in epidemiology, data analytics, and communications to support healthcare providers in understanding and applying advanced epigenetic testing into clinical practice.

Jamie, the Vice President of Operations and Head of Compliance, brings 15 years of experience in the dental and telehealth sectors. A native of North Carolina, Jamie is married to her high school sweetheart and is a proud mother of one daughter and two pup dogs. With a proven track record in building and optimizing high-performing teams, she leads initiatives in IT operations, security, compliance, and company-wide operations. Jamie is passionate about bringing structure to chaos, helping others not only excel in their roles but also enjoy their work. She’s equally committed to guiding other leaders in achieving balance in their professional and personal lives.

Katherine Gruneisen is the Executive Vice President and Head of Marketing at TruDiagnostic and Infinite Epigenetics, where she leads initiatives to build brand equity, drive commercial growth, and advance the company's mission of building novel diagnostics with epigenetics. Katherine earned her MBA from the Stanford Graduate School of Business and holds dual B.S. degrees in Finance and Marketing with honors from the University of Virginia's McIntire School of Commerce. She brings a wealth of leadership experience, having previously led teams in brand strategy, sales, and e-commerce across the health, technology, and consumer sectors. Katherine's career spans a diverse range of business sizes as well, from the smallest of startups to Fortune 500 companies. Her passions lie at the intersection of brand storytelling and the transformative power of precision medicine. Katherine is committed to advancing education and access to epigenetic insights, driving the company's role as a leader in the field.

Tavis has a PhD in Pathobiology with experience in Molecular Biology and Biochemistry techniques. With over 2 decades of laboratory experience across North America and Asia, he has gained insight in lab management and upholding standards of several Federal guidelines such as IACUC and CLIA. Tavis’ focus was lipidology and genetics of an intestinal parasite which helped secure a $2.1 million dollar grant from the National Institute of Health (NIH). Acquiring several other grants such as the Research Training Initiative for Student Enhancement (RISE), Tavis was able to work in the fields of cancer and hypertension, learning several scientific techniques to power the studies such as Mass Spectrometry and Confocal/Electron Microscopy. With his scientific background, Tavis has always been devoted to studying nutrition, lifestyle and its effect on human health. Now at TruDiagnostic, he is applying this passion using microarray technology for epigenetics as Lab Director. With this state-of-the-art platform, he seeks to push forward research in aging and well-being to advance the field of preventative healthcare.

Jordan serves as the Chief of Staff at TruDiagnostic, where she contributes to advancing the company’s mission in epigenetic research and healthspan optimization. With a background in mechanical engineering from the University of Kentucky, Jordan applies an analytical approach to her work. Her experience includes running operations at Wild Labs and co-founding Harbor Behavioral Health, where she learned how to navigate the challenges of scaling startups and improving organizational efficiency. At TruDiagnostic, Jordan is responsible for streamlining operations, aligning the team with strategic goals, and fostering a collaborative, supportive work culture. She is dedicated to ensuring that the company’s operational excellence supports its cutting-edge work in epigenetics. Jordan’s focus on building efficient systems and nurturing innovation continues to play a key role in the company’s growth and success.

Dr. Melissa Keinath is a board-certified laboratory geneticist with over 10 years of experience in clinical cytogenetic and molecular genetic analysis. She earned her Ph.D. from the University of Kentucky, where she studied complex vertebrate genomics and taught graduate-level bioinformatics. She later completed postdoctoral training at the Carnegie Institution for Science, focusing on lampbrush chromosome cytogenetics and epigenetic modifications, while also teaching Practical Genomics at Johns Hopkins University. Melissa then completed a three-year clinical fellowship in laboratory genomics and genetics at Case Western Reserve University/University Hospitals. She currently serves as TruDiagnostic's CLIA Laboratory Director.

Dr. Varun Dwaraka, PhD, FRSB, serves as Director of Research and Principal Investigator at TruDiagnostic, a CLIA-certified DNA methylation diagnostics company and one of the largest epigenetic testing laboratories in the world. As one of the company's founding scientists, he leads a team developing advanced bioinformatics pipelines and machine learning methods to identify epigenetic biomarkers and build predictive models at the intersection of aging, disease, and mortality risk. His work spans epigenetic clock development, multi-omic data integration, interventional trial analysis, and AI-assisted scientific workflows for DNA methylation research. Dr. Dwaraka holds a Bachelor of Science in Molecular, Cellular, and Developmental Biology from the University of California, Santa Cruz, and a PhD in Biology from the University of Kentucky. Much of his research sits at the intersection of multi-omics and biological aging, with work appearing in Nature Aging, Nature Medicine, Nature Communications, Genome Medicine, BMC Medicine, and npj Aging. A central thread across this body of work has been building more informative measures of biological age: he led development of OMICmAge, a clock that integrates proteomic, metabolomic, and clinical data with DNA methylation to produce a richer picture of how and why individuals age differently, and led the development of DeepStrataAge as a complementary stratified approach. More recently, he has led the epigenetic analysis on several high-profile intervention studies, contributing to the first randomized, placebo-controlled evidence that semaglutide slows biological aging. He currently holds an i10 index of 26 as of June 2026. His research has attracted coverage from Forbes, BBC, The Times of London, Newsweek, Men's Health Magazine, and The Aesthetic Magazine, and has been featured in documentaries on HBO and Netflix. Beyond TruDiagnostic, Dr. Dwaraka serves as faculty at the Geneva College of Longevity Science and as Director of Epigenomics on the American Board of Precision Medicine, and contributes to multiple scientific advisory boards focused on epigenetics and precision medicine. His scientific contributions have been recognized through full membership in Sigma Xi, The Scientific Research Honor Society; designation as a 2023 Foresight Fellow in Biotechnology and Health Expansion, awarded by the Foresight Institute; and election as a Fellow of the Royal Society of Biology (FRSB).

Hannah has a lifelong passion for longevity and breakthrough, disruptive technologies that drive radical improvement to the human condition. She attended the University of Kentucky and graduated with a degree in Biology. During that time, she had multiple research internships studying cell signaling and cell biology. After graduation, she worked for the International Peptide Society as their Director of Research and Content. Through work in the integrative medicine industry, Hannah saw an opportunity for methylation based age diagnostics and started TruDiagnostic in 2020. TruDiagnostic is a company focusing on methylation array-based diagnostics for life extension and preventive healthcare serving functional medicine providers. TruDiagnostic has a commitment to research with over 30 approved clinical trials investigating the epigenetic methylation changes of longevity and health interventions. Since TruDiagnostic’s inception, they have created one of the largest private epigenetic health databases in the world with over 75,000 patients tested to date. Hannah has since created Everything Epigenetics where she shares insights on how DNA regulation has an impact on your health.

Chris is a seasoned technology leader with a rich background in both software engineering and athletics. Graduating from Texas A&M University in 2006 with a BS in Computer Science, Chris distinguished himself not only in the classroom but also on the court as a starter for the Texas A&M Men's Basketball team from 2004-2006. His ability to balance rigorous academics with the demands of collegiate sports laid the foundation for his future success. Chris is the visionary founder of two innovative SaaS platforms. His first venture was the pioneering cloud-based Test & Balance engineering platform, a tool that facilitated the synchronization of data from remote clients to a central server. His second venture was a cloud marketplace designed for trainers to distribute exercise programs and for athletes to track their progress. Over the past 13 years, Chris has led engineering teams across various domains, including healthcare, exercise & nutrition, Test & Balance engineering, and heat transfer engineering. His expertise lies in guiding teams to build distributed cloud applications and in leveraging Large Language Models (LLMs) to create industry leading products.

Dr. Mike is a board certified emergency physician and practicing precision medicine physician with over a decade of experience in the integration of generative AI, product management, and user experience design within the healthcare sector. Currently serving as the Chief Experience Officer at TruDiagnostic, Dr. Mike leads the development and implementation of innovative epigenetic diagnostic products, focusing on enhancing both clinical utility and user engagement. Dr. Mike's career is marked by significant contributions to precision medicine. As a co-founder of Wild Health, he played a pivotal role in advancing personalized healthcare, achieving notable outcomes in chronic disease management through lifestyle interventions. His expertise extends to the development of AI-driven health coaching platforms, as demonstrated by his work at Holis, where he oversees the integration of biometrics, genetics, and laboratory data into personalized wellness programs. In addition to his leadership roles, Dr. Mike has a strong academic background, with over 20 peer-reviewed publications in the fields of precision medicine and emergency ultrasound. His work has consistently focused on translating complex scientific research into practical healthcare solutions, with a commitment to improving patient outcomes through the application of advanced technologies.

Dr. Matthew attended medical school at The University of Kentucky before completing his residency in emergency medicine at The University of Utah, where he served as both chief resident and fellow. After practicing medicine and serving as an associate professor at the University of Kentucky for seven years, Dr. Matt developed a deep interest in genomics and epigenetics, realizing their potential to revolutionize our understanding of health and longevity. As the CEO of TruDiagnostic, Dr. Matt leads the company's mission to advance the science of epigenetics and provide groundbreaking insights into aging and disease prevention. His dedication to optimizing human performance, which began with his personal focus on fitness and nutrition, has evolved into a professional pursuit of harnessing epigenetic data to extend health span and improve overall well-being. Under his leadership, TruDiagnostic is at the forefront of epigenetic testing and research, empowering individuals and researchers with actionable information about biological aging, disease susceptibility, and personalized health strategies. Dr.Matt passion for using cutting-edge science to impact lives is evident in his efforts to bridge the gap between epigenetic research and practical healthcare applications. He has trained physicians and healthcare providers in the importance of epigenetic markers, ensuring that TruDiagnostic's work continues to push the boundaries of what's possible in preventive health. He regularly shares insights through public speaking and educational platforms, advocating for the role of epigenetics in reshaping healthcare. Fast Facts: Started a landscaping business in middle school and sold it in high school Co-owner & Chief Farming Officer of the Kentucky Castle Co-Founder of Wild Health Co-Founder of Ultrasound Leadership Academy